Healthcare - Biotechnology - NASDAQ - CH
$ 3.13
-6.29 %
$ 7.74 M
Market Cap
-0.46
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
501.65%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NLS Pharmaceutics AG
NLSP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart NLSP
EBIT FORECAST
EBIT Forecast Chart NLSP
NET INCOME FORECAST
Net Income Chart NLSP